Introduction
============

The symbiotic gut microbiome exerts a strong influence on the metabolic phenotype of the mammalian host and participates in extensive microbial--mammalian co-metabolism ([@b12]; [@b71]; [@b3]; [@b13]; [@b22]; [@b42]; [@b16]; [@b33]; [@b38]; [@b60]). Gut microbial composition is now known to vary significantly in obese animal ([@b60]) and human ([@b29]) populations, and recent studies have shown that the exact state of the gut microbial ecology and metabolic activities may be of fundamental importance in the control of calorific absorption ([@b70]; [@b2]) and in the development of insulin resistance and nonalcoholic fatty liver disease in high-fat-diet experiments ([@b11]). We know that the symbiotic gut microbiome acts as an extended genome ([@b28]) and has evolved to exert control on a number of important mammalian metabolic regulatory functions ([@b12]; [@b47]; [@b71]; [@b70]; [@b2; @b3]; [@b22]; [@b42]; [@b11]; [@b16]; [@b33]; [@b53]). Gut microbes extensively co-metabolize bile acids and these have mammalian endocrine functions ([@b24]; [@b63]).

The integrated metabolism of the bile acid pools in mammals is a good example of the complex transgenomic biochemical interactions between host and microbiome symbionts as summarized in [Figure 1](#f1){ref-type="fig"}. Bile acids are synthesized from cholesterol in the liver by a multi-enzyme coordinated process ([@b46]) and are crucial for the absorption of dietary fats and lipid-soluble vitamins in the intestine ([@b54]). Bile acids also have a role in maintaining the intestinal barrier function to prevent intestinal bacterial overgrowth and translocation ([@b32]; [@b44]), as well as invasion of underlying tissues by enteric bacteria ([@b44]). In addition, abnormal bile acid profiles are indicative of various hepato-gastrointestinal diseases, such as dietary fat malabsorption and gallstone formation ([@b6]; [@b26]) and might have an essential role in regulating obesity or type II diabetes ([@b24]; [@b63]). Many so-called secondary bile acids (deoxycholic, lithocholic, hyodeoxycholic and ω-muricholic acids) can be regarded as examples of mammalian-microbiotal co-metabolism ([@b42]) and have different metabolic fates via enterohepatic recirculation ([@b41]). This is part of what we term the microbiome--host metabolic axis, which we define here for the first time as 'the multi-way exchange and co-metabolism of compounds between the host organism and the gut microbiome resulting in transgenomically regulated secondary metabolites, which have biological activity in both host and microbial compartments\'. Understanding the effects of bacterial metabolism on the balance of bile acids in enterohepatic recirculation is a major challenge owing to the implications of microbiota in fat absorption, lipid metabolism, drug therapeutic or toxic effects as well as direct effects within the gastrointestinal tract and its contents ([@b61]). In this regard, recent advances in microbial and metabolic profiling now enable the multi-compartment study of bile acids and their effect on intermediary metabolism.

The application of high-resolution ^1^H nuclear magnetic resonance (NMR) spectroscopy of biofluids and tissues coupled with multivariate statistical methods is a well-established tool for untargeted metabolic profiling ([@b43]; [@b39], [@b42]; [@b62]). Hyphenated chromatographic-mass spectrometric methods such as ultra-performance liquid chromatography--mass spectrometry (UPLC--MS)-based profiling techniques have also been recently used effectively for functional genomic discrimination ([@b48]; [@b67]). Lately, LC--MS has been shown to be a sensitive and quantitative method of analysis for identification of major bile acids in urine and plasma ([@b34], [@b35]). Historically, bile acid analysis has been hindered by difficulties in separating many structurally similar compounds and isomers in a highly complex matrix. We have now developed and show here for the first time an enhanced bile-acid-targeted profiling method using UPLC--MS, which gives superior chromatographic resolution and sensitivity ([@b67]; [@b49]) and greatly aids the study of bile acid metabolism.

In the present study, the complex metabolic response of the host to perturbation of its enteric microbiota at the systems level by integration of metabolic data from many compartments was investigated. The aim of the study is to assess the effects of the induction of a nonadapted microflora in a murine model (human baby flora (HBF)) on the host metabolism by comparison with animals colonized with a natural gut microflora (conventional), the result of a long period of co-evolution. An additional group of germfree mice, naturally re-conventionalized, was used as a control to investigate the specific effects related to the re-establishment of a flora in previously germfree mice. Here, we have integrated the effects of modulation of the microbiome in mouse models on major bile acids co-metabolism through targeted metabolic profiling, and characterized the consequences of this intervention at the systems level through parallel untargeted metabolic profiling, multivariate and graph modeling. Here, we show a significant association of specific metabotypes and changes of the gut microbiome between mice colonized naturally with a conventional microflora or colonized with a defined microbial population derived from human host in a pathogen-free environment, that is, HBF. This study brings further evidence that gut microflora is adapted to each host and that gut microflora influences the host\'s systemic lipid metabolism and energy balance through modification of bile acid metabolism and eventually impacts on the host\'s health.

Results
=======

Gut bacterial composition and fecal content of short-chain fatty acids
----------------------------------------------------------------------

Microbiological profiles were used to assess the stage of bacterial development during re-conventionalization and colonization with an HBF. The terminal composition of the fecal microbiota is detailed in [Table I](#t1){ref-type="table"}. Using a two-tailed Mann--Whitney test, we showed that after 32 days of natural re-conventionalization, the mice have similar microbial composition in feces as conventional animals, although their levels of *Bacteroides* and *Enterobacteria* were higher ([Table I](#t1){ref-type="table"}). The HBF mice had markedly different gut microbiota characterized by an important population of *Clostridium* and higher levels of *Bacteroides* and *Enterobacteria* as those observed in re-conventionalized mice when compared to conventional mice ([Table I](#t1){ref-type="table"}).

The fecal content of individual animals was investigated using gas-chromatography--flame-ionization-detection (GC--FID) to identify and quantify some major bacterial short-chain fatty acids (SCFAs), namely acetate, propionate, isobutyrate, *n*-butyrate, *n*-valerate and isovalerate. Although lactate changes were expected, they were not in fact measured. The results presented in [Table II](#t2){ref-type="table"} are given in μmol/g of dry fecal content, and as mean±s.d. for each group of mice, and were assessed using a two-tailed Mann--Whitney test. The production of SCFAs by the gut microbiota of re-conventionalized mice was similar to that of conventional mice, except that the latter has higher levels of acetate. These SCFAs were found in lower concentrations and in different proportions in HBF mice ([Table II](#t2){ref-type="table"}). In particular, a higher proportion of propionate (24.5±4%) and a lower proportion of *n*-butyrate (4.2±3.4%) were observed in HBF mice (controls were 10.2±1.2 and 11.1±3.4%, respectively).

^1^H NMR spectroscopy of mouse plasma, urine, liver and ileal flushes
---------------------------------------------------------------------

Examples of typical ^1^H NMR spectra of urine, ^1^H CPMG NMR spectra of liver and plasma from an HBF mouse, and ^1^H NMR spectra of ileal flushes from HBF and conventional mice are shown in [Figure 2](#f2){ref-type="fig"} and were assigned according to literature ([@b40]; [@b59]; [@b62]), and confirmed by selected ^1^H-^1^H correlation spectroscopy (COSY) ([@b25]) and ^1^H-^1^H total correlation spectroscopy (TOCSY) ([@b4]) two-dimensional (2D) NMR experiments on single sample as well as selective statistical total correlation spectroscopy (STOCSY) ([@b8]) experiments on multiple samples. In particular, NMR spectroscopy detects a wide range of amino acids, metabolism intermediates, organic acids, membrane components, saturated and unsaturated triglycerides and fatty acids, ketone bodies, *N*-acetyl and *O*-acetyl-glycoproteins ([Table III](#t3){ref-type="table"}). Indoleacetylglycine (IAG), phenylacetylglycine (PAG), trimethylamine (TMA), trimethylamine-*N*-oxide (TMAO) and dimethylglycine (DMG) were also identified in urine. Using NMR, five bile acid species were assigned unambiguously in ileal flushes, that is, β-muricholic (βMCA), tauro-β-muricholic (TβMCA), cholic (CA), taurocholic (TCA) and tauroursodeoxicholic (TUDCA) acids. ^1^H NMR spectra of pure compound showed that the ^1^H NMR chemical shifts of C-18, C-19 and C-21 methyl groups were characteristic for the determination of individual bile acid levels. However, this method is of limited use for probing complex mixtures and for differentiating conjugated from unconjugated forms of bile acids in such mixtures.

^1^H NMR spectral complementary data sets from plasma, urine, liver tissue or ileal flushes were analyzed using orthogonal partial least squares discriminant models (O-PLS-DA) ([@b58]) to maximize the discrimination of experimental groups and focus on metabolic variations explained to gut flora changes ([Figure 3](#f3){ref-type="fig"}). The characteristics of the models generated are summarized in [Table IV](#t4){ref-type="table"}. O-PLS-DA revealed significant variations in the metabolic profiles from plasma, liver and urine between conventional and re-conventionalized animals ([Table IV](#t4){ref-type="table"}). Re-conventionalized mice had higher levels of plasma GPC and choline, lower urinary concentrations of guanidinoacetate and lower levels of liver glycogen (data not shown).

Significant and predictive discrimination of plasma, liver, urine and ileal flushes between conventional and HBF mice was achieved using O-PLS-DA, as denoted by high Q^2^Y values ([Table IV](#t4){ref-type="table"}). The corresponding coefficient plots show the key metabolites in plasma, liver, urine and ileal flushes that contribute to the separation ([Figure 3](#f3){ref-type="fig"}). Decreases in levels of lipoproteins and pyruvate, and increased levels of GPC, choline, acetate and glutamine were observed in the plasma of HBF mice when compared to conventional animals ([Figure 3A](#f3){ref-type="fig"} and [Supplementary Figure 1](#S1){ref-type="supplementary-material"}). The liver of HBF mice also showed higher levels of triglycerides and lower concentrations of glycogen, lysine, arginine, asparagine, aspartate, glutamine and glutathione ([Figure 3B](#f3){ref-type="fig"} and [Supplementary Figure 1](#S1){ref-type="supplementary-material"}). Urinary profiles of HBF mice showed lower levels of PAG, tryptamine and an unknown metabolite (U1), and higher levels of β-alanine, 3-hydroxy-isovalerate, *N*-acetyl signals from glycoproteins and a putative glycolipid as discussed earlier ([Figure 3C](#f3){ref-type="fig"}). Differences in the ileal flushes were also characterized with higher levels of TβMCA and lower levels of CA and TUDCA ([Figure 3D](#f3){ref-type="fig"}).

UPLC--MS analysis and ileal content in bile acids
-------------------------------------------------

To complement the bile acid profiling achieved by NMR, we also analyzed ileal flushes using UPLC--MS. Typical negative ion chromatograms for the bile acids detected in the ileal flush of a conventional mouse are shown in [Figure 4](#f4){ref-type="fig"}. A total of 14 bile acids were identified by comparison with a series of 22 bile acid standards. Three additional bile acid components, identified as U1 (*m*/*z*=453.2, RT=2.70), U2 (*m*/*z*=437.2, RT=4.44) and U3 (*m*/*z*=491.2, RT=1.53), were also observed. Unconjugated muricholic and cholic acids with mass to charge ratio of *m/z=*408.2 were detected at *m/z=*453.2 due to the formation of a formate adduct (45 Da).

The relative bile acid compositions in ileal flushes from the different groups are given in [Table V](#t5){ref-type="table"}, and are shown as mean±s.d. of the percentage of the total bile acid content. UPLC--MS analysis showed that conventional and re-conventionalized mice had specific bile acid profiles---14 bile acids were identified, the most abundant species being CA, TCA, TβMCA and TUDCA. HBF animals showed lower diversity in their bile acid composition, predominantly containing TβMCA and TCA as well as CA, αMCA, βMCA, TCDCA, TUDCA and putative unknown bile acid U3.

A comparison of concentrations of bile acids obtained from HBF re-colonized mice with those from conventional mice using an O-PLS-DA strategy revealed that conventional mice showed lower amounts of taurine conjugates such as TβMCA and TCA, and a higher amount of CA, which is in agreement with the observations obtained by ^1^H NMR spectroscopy ([Figure 5A](#f5){ref-type="fig"}). A weak discrimination was also obtained between conventional and re-conventionalized animals ([Figure 5B](#f5){ref-type="fig"}), with the latter showing lower levels of CDCA and GCA, and higher concentrations of TβMCA.

Effect of major bile acids on tissue-specific metabolic profiles
----------------------------------------------------------------

The effect of TCA and CA on the enterohepatic recirculation was assessed by OPLS regression, using the NMR-based metabolic profiles from intact liver tissues and ileal luminal content as **X** input and CA (or TCA) levels obtained by UPLC--MS as **Y** ([Figure 6](#f6){ref-type="fig"}). The ^1^H NMR metabolic profiles obtained from ileal flushes ([Figure 6B and D](#f6){ref-type="fig"}) show a marked anticorrelation between TCA and CA, these two major bile acids operating as 'anchor\' metabolites. There is a positive correlation between conjugated taurine and taurine-conjugated bile acids, that is, TCA and TβMCA. This cluster of conjugated species is anticorrelated to free species, that is, CA and free taurine, consistent with a bacterial deconjugation of bile acids in the ileum. In the liver ([Figure 6A and C](#f6){ref-type="fig"}), the situation is reversed, with TCA (CA) being correlated (anticorrelated) with free taurine, highlighting the fact that the conjugation process is restricted by the available amount of taurine (substrate).

Integration of correlations between bile acids and fecal flora
--------------------------------------------------------------

A novel correlative analysis was performed to investigate the cross-compartment connections between fecal flora and bile acids in the intestinal lumen. Bipartite graphs were used to visualize correlations (above a given cutoff) between fecal bacteria and bile acids (see Materials and methods and [Figure 7](#f7){ref-type="fig"}). Conventional and HBF mice show very different bile acid/fecal flora correlation networks ([Figure 7A and B](#f7){ref-type="fig"}). Network statistics given for several correlation cutoffs ([Figure 7C](#f7){ref-type="fig"}) reveal that microbiome/metabolome bipartite graphs from HBF mice show in general lower complexity than conventional mice. In particular, for ∣*r*∣\>0.5, we observed that in the conventional flora network of degree 9, the most connected bacteria are *Lactobacilli* (correlated to nine different bile acids, [Figure 7A](#f7){ref-type="fig"}). HBF mice are supplemented with one *Lactobacillus* strain (*Lactobacillus paracasei*) for which only one functional correlation is significant, whereas the most connected bacteria are *Enterobacteria* (*Escherichia coli*) (correlated to three bile acids; [Figure 7B](#f7){ref-type="fig"}).

Discussion
==========

We have investigated the host\'s metabolic response to perturbation of its enteric microbiota at the systems level, using multiple compartment information deriving from 'state-of-the-art\' metabolic profiling technologies combined with novel data analysis methods. A significant association between changes of the gut microbiome and specific metabotypes (obtained from urine, plasma, intact liver tissue and ileal flush) in mice was shown. This study brings further evidence that gut microbiota modulates the host systemic lipid metabolism through (i) modification of bile acid metabolic patterns, impacting directly on (ii) emulsification and absorption properties of bile acids and then indirectly on (iii) storage of fatty acids in liver and (iv) lipoperoxidation through bile acid signaling properties, as detailed below ([Figure 8](#f8){ref-type="fig"}).

Modulation of bile acid conjugative patterns by gut microbiota
--------------------------------------------------------------

The various properties of bile acids provide a complex signaling system in which the gut microflora finely interacts with the host\'s metabolism. Previous analyses in rodents ([@b15]) reported that the liver secretes almost 100% tauro-conjugated bile acids in the bile (typically 60% TβMCA and 40% TCA). In our study on conventional and re-conventionalized mice**,** primary, secondary and tertiary bile acids are observed as unconjugated, tauro- and glyco-conjugated species ileal flushes ([Table V](#t5){ref-type="table"}). These observations illustrate the ability of 'healthy and normal\' gut microbiota ([@b23]) to deconjugate bile acids and modify them as detailed in [Figure 1](#f1){ref-type="fig"} and previously ([@b10]; [@b50]). The bacterial composition of HBF implemented in a murine gastrointestinal ecosystem is similar to that found in human gastrointestinal tracts ([@b2]; [@b27]). It is also significantly different from conventional microbiota in terms of bacterial species and relative composition, that is, higher levels of *Enterobacteria* and *Bacteroides* ([Table I](#t1){ref-type="table"}). Our results show that significant variations in microbial populations lead to modification of bile acid symbiotic metabolism in the ileal lumen ([Figures 3](#f3){ref-type="fig"} and [5](#f5){ref-type="fig"}; [Table V](#t5){ref-type="table"}). Furthermore, similar to HBF mice, re-conventionalized mice also show elevated levels of *Enterobacteria* and *Bacteroides* and high concentrations of TβMCA when compared to conventional mice ([Figure 5](#f5){ref-type="fig"}). The deconjugation of bile acids involves the activity of bile salt hydrolase, which is synthesized in significant amounts by *Lactobacillus* and *Bifidobacteria* ([@b10]). Alltogether, these observations suggest that the balance between *Lactobacillus* and *Bifidobacteria* and *Enterobacteria*, *Bacteroides* might be essential in the deconjugation of TβMCA.

To investigate transgenomic metabolic interactions, we show for the first time the use of bipartite graphs to display correlation patterns between fecal flora and bile acids ([Figure 7](#f7){ref-type="fig"}). These graphs show the fine relationship between specific gut microbial population modulation and bile acid co-metabolism. For instance, the elevated concentrations of TβMCA in HBF mice correspond to a relative inability of HBF to deconjugate murine bile acids ([@b51]) and to transform further TβMCA into derivatized bile acids, such as ùMCA ([@b52]) or HCA ([@b14]) ([Figure 1](#f1){ref-type="fig"} and [Table V](#t5){ref-type="table"}). The overwhelming contrast between the simplicity of HBF mice and the complexity of conventional mice bipartite networks ([Figure 7](#f7){ref-type="fig"}) highlights the contrast between the restrained abilities of the few bacterial strains composing HBF to transform bile acids, on the one hand, and the metabolic flexibility of conventional mice, on the other hand, whereby the conventional murine bacterial strains communicate with each other and disperse their metabolic functions to synthesize additional bile acids (DCA, CDCA, UDCA, ωMCA, HCA, GCA, TDCA). In this regard, the synthesis of ωMCA appears as a good example as it can only be achieved by specific bacterial strains ([@b52]) or through bacterial cooperation ([@b14]). In this regard, this lower complexity of the HBF bipartite network suggests lower metabolic flexibility and robustness.

The potential role of microbiome in fat emulsification and absorption
---------------------------------------------------------------------

We observe a shift in the bile acid pattern towards tauro-conjugates in HBF, which can be explained by a lower deconjugation activity from the microbiota. Bile acids are amphiphilic (hydrophobic and hydrophilic) compounds and conjugation modifies their hydrophobic/hydrophilic balance, which directly relates to lipid emulsification and eventually absorption ([@b1]; [@b19]; [@b20]). Tauro-conjugation of bile acids reduces the hydrophobic/hydrophilic ratio and increases their solubility and lipid emulsification. On the contrary, deconjugated bile acids are less effective in emulsification of dietary lipids and micelle formation ([@b1]; [@b19]; [@b20]; [@b37]; [@b56]). Here, we show that HBF mice have lower levels of CA and higher levels of TCA and TβMCA ([Figures 3](#f3){ref-type="fig"} and [5](#f5){ref-type="fig"}), with ratios of TCA:CA of 118.8 and TβMCA:βMCA of 52, whereas conventional mice showed ratios of TCA:CA of 1.4 and TβMCA:βMCA of 24 ([Table V](#t5){ref-type="table"}). These biochemical changes towards increasing lipid emulsion efficiency of the bile acid mixture ([@b54]; [@b66]) were also shown to modify the hepatic phase II taurine conjugation activity as described by the strong correlation between taurine concentration in the liver and ileal bile acid composition ([Figure 6](#f6){ref-type="fig"}). This data integration clearly shows two opposite biological mechanisms: the tauro-conjugation process of CA into TCA in the liver, which is counterbalanced by a bacteria-mediated deconjugation process in the intestinal tract (ileum). Moreover, HBF mice show higher urinary excretion of β-alanine, which is a competitive inhibitor of taurine uptake in kidney and liver as it shares the same transporter ([@b5]). The differences in β-alanine elimination also illustrate the different requirements of taurine in the metabolism of bile acids, which is consistent with higher demands in conventional animals for conjugation of bile salts. Our observations suggest increased hydrophilicity of the bile acid pool in HBF and re-conventionalized mice, which would lead to higher intestinal absorption of dietary lipids and higher enterohepatic recycling of bile acid pool when compared to conventional animals. Recent findings support our results with suggestion of the essential microbial role in affecting bile acid-controlled signaling pathways involved in energy and lipid metabolism ([@b24]; [@b63]). In particular, endogenous bile acids and derivates such as UDCA and TUDCA were shown to be chemical chaperones (osmolytes) with antidiabetic properties ([@b45]). Hence, the perturbation of the microbiota by modifying bile acid metabolism may ultimately affect the nutritional and wider health status of the host.

The gut microbiota modulate lipid metabolism in the host
--------------------------------------------------------

The essential role of gut microbiota on serum lipid levels in humans has gained interest recently, in relation to the possible etiology of cardiovascular diseases ([@b47]). For instance, cholesterol-lowering effects were reported for *Lactobacillus* and *Bifidobacteria,* as well as protection against VLDL and LDL oxidation ([@b57]; [@b69]). These observations are consistent with previous findings that the microbiota promote storage of triglycerides in adipocytes via indirect modulation of cellular fatty acids uptake, secretion of apolipoproteins and adipocyte triglyceride accumulation ([@b2]; [@b11]). [@b30], [@b31] and [@b64] demonstrated that an increase in the intracellular bile acids concentration (in particular TCA) and decrease in hepatic bile acid synthesis inhibit the synthesis and secretion of VLDL-associated triglycerides from hepatocytes as well as the secretion of the apolipoprotein associated with transport of VLDL, namely apoB-100. These previous results indicate that bile acids might play a physiological role in regulating VLDL production by the liver, the enterohepatic circulation acting as a feedback loop. This provides a mechanistic model in which the symbiotic microbiota can modulate the host\'s lipid metabolism. The gut bacterial--mammalian metabolic interactions related to bile acid and lipid metabolism are summarized in [Figure 8](#f8){ref-type="fig"}.

A microflora nonadapted to mice modulates the physiology of the host towards a pre-pathologic state
---------------------------------------------------------------------------------------------------

In the present study, mice re-colonized with HBF show decreased plasma lipoproteins concentration (mainly VLDL and LDL), increased glycerol, GPC and choline in plasma and increased hepatic triglyceride concentrations ([Figure 3](#f3){ref-type="fig"}). Our results suggest that the higher enterohepatic recycling of TCA and TβMCA associated with higher intestinal absorption of dietary lipids in HBF mice leads to reduced synthesis and secretion of VLDL-associated triglycerides, and consequently accumulation of lipids in the liver and reduction of VLDL and LDL concentrations in plasma.

Such findings have to be interpreted simultaneously with lower concentrations of glutathione observed in the liver from HBF mice ([Figure 3](#f3){ref-type="fig"}). Glutathione plays important roles in nutrient metabolism and antioxidant defense: depletion in glutathione contributes to oxidative stress, involved in the pathogenesis of several diseases, including cancer, liver disease, heart attack and diabetes ([@b68]). Previous observations reported reduced glutathione levels in the liver of rats fed with cholesterol plus cholic acid ([@b7]; [@b17]), which is consistent with the observed higher intestinal absorption of dietary lipids and enterohepatic recycling of bile acid pool in HBF mice. Reprocessing of fatty acids and subsequent generation of radical oxidative species result in higher oxidative stress, this situation leading to peroxidation of hepatic lipids and eventually liver disease ([@b68]). Such glutathione depletion can be reached either by nutritional deficiency or by increased glutathione peroxidase and glutathione reductase activities in tissues. High oxidative stress denotes an increased lipoperoxidation risk ([Figure 8](#f8){ref-type="fig"}). Altogether, our observations suggest that HBF is not a sustainable flora for mice, which might result in impaired liver functions.

In conclusion, both systemic and tissue-specific metabolic changes across a wide range of metabolic pathways and metabolite classes indicate the deep extent of host--microbiota co-metabolic interactions. This work strongly supports the idea that several complex metabolic disease traits can be influenced by the gut microbiota.

In this study, we have shown that re-conventionalization of mice normalizes their metabolism towards a healthy physiology. This metabolic convergence strikingly contrasts with our observations in the HBF model. We report that HBF is not a sustainable flora for mice, which modifies the physiology of the murine host towards a pre-pathologic state. Whereas re-conventionalized mice evolve to normal gut flora from an ecological point of view, HBF supplementation maintains the gut tract and the liver out of a sustainable mouse ecological equilibrium, as denoted by higher numbers of *Clostridium perfringens* ([Table I](#t1){ref-type="table"}). The metabolic consequences for the host show an increase in lipid accumulation in liver (despite a decrease in lipoprotein sub-fractions in blood) associated to a higher lipoperoxidation risk. We also observed the critical involvement of the microbiome in supplying host calorific requirement via caloric recovery through fibers fermentation. In this case, gut bacteria exert modulation over the host metabolism via reprocessing of signaling molecules, that is, bile acids, that might be involved in common metabolic diseases such as obesity or type II diabetes ([@b24]; [@b45]; [@b63]). As such, bile acids may be an example of transgenomic mechanism of *quorum sensing* ([@b42]), whereby microbial cells communicate with each other and disperse their metabolic functions, thus behaving like a multicellular organism.

Metabolic profiling on conventional mice, compared to HBF animals, showed that the gut microflora are an essential evolutionary driver towards providing more refined control mechanisms on the host\'s physiology, which ultimately determine host nutritional status and health. Our results suggest that controlling the dynamics of the gut microbiome to maintain or re-establish a balanced and well-adapted microflora could help to prevent some microbial-related metabolic disorders such as hepato-gastrointestinal diseases.

Materials and methods
=====================

Animal handling procedure and probiotic administration
------------------------------------------------------

All animal studies were carried out under appropriate national guidelines at the Nestlé Research Center (Lausanne, Switzerland). The HBF strains were isolated from stool from a 20-day-old female baby, who was naturally delivered and breast-fed as described previously ([@b18]). The HBF flora contained only the following strains of bacteria: *E. coli, Bifidobacteria breve, B. longum, Staphylococcus epidermidis, S. aureus, C. perfringens* and *Bacteroides.* After 48 h at 37°C (24 h for *E. coli, S. aureus* and *S. epidermidis*), the number of bacteria for each strain was estimated as described previously ([@b18]) and were mixed at equal amounts (10^10^ cells/ml for each strain) for gavage. Bacterial cell mixtures for inoculation were kept in frozen aliquots with their spent culture medium until use. *L. paracasei* was obtained from the Nestlé Culture Collection (Lausanne, Switzerland) and grown under anaerobic conditions in Man-Rogosa-Sharpe (MRS) culture medium.

A total of 26 C3H female mice, aged 6 weeks, were fed with a standard pathogen-free rodent diet (Nestlé, Switzerland). A group of conventional mice was kept as control (*n*=9). One group of germfree mice was re-conventionalized by removal from their germfree isolator and exposure to normal environment for a period of 4 weeks (*n*=10). A second group of germfree mice received a single dose of HBF (*n*=7) by oral gavage and 2 weeks later, they were given *L. paracasei* probiotic by mixing aliquots of 1 ml probiotics (4 × 10^9^ cells/ml) with 200 ml of saline under pathogen-free conditions for a period of 2 weeks. As each mouse drinks on average 5 ml/day, each mouse received around 10^8^ probiotic bacteria per day, which allows maintaining the probiotic population in a steady state within the gut environment. Animals were euthanized after 4 weeks and microbial analysis was carried out on fecal samples as described previously ([@b18]). Urine was collected from mice before killing upon holding them by immobilization grip and urine was snap-frozen immediately. Blood (400 μl) was collected into Li-heparin tubes and the plasma was obtained after centrifugation and frozen at −70°C. The liver was dissected and snap-frozen. The intestine from the stomach to the cecum was removed from each animal. The first 1 cm length after the stomach was considered to be duodenum and the rest was divided into three sections: the first 2/3 was designated as jejunum and the remaining 1/3 as ileum. Three-centimeter samples (3 cm) were excised from the middle of each section. Ileal flush samples were obtained by rinsing the ileal lumen with 1 ml of a phosphate buffer solution (0.2 M Na~2~HPO~4~/0.04 M NaH~2~PO~4~ (pH 7.4)) using a 1-ml sterile syringe. Samples were retrieved in Eppendorf tubes and snap-frozen before NMR spectroscopy and UPLC--MS analyses. Samples included five flush samples from conventional and re-conventionalized mice and seven flush samples from HBF colonized mice. Cecal content was collected upon animal autopsy, snap-frozen immediately and kept at −80°C before analysis.

Microbial profiling of fecal contents
-------------------------------------

Briefly, for each mouse, one fecal pellet was homogenized in 0.5 ml Ringer solution (Oxoid, UK) supplemented with 0.05% (w/v) [L]{.smallcaps}-cysteine (HCl), and different dilution of the bacterial solution were plated on selective and semiselective media for the enumeration of specific microorganisms: *Bifidobacteria* on Eugom Tomato medium, *Lactobacillus* on Man, Rogosa and Sharpe (MRS)+antibiotics (phosphomycine, sulfamethoxazole and trimethoprime) medium, *C. perfringens* on NN-agar medium, Enterobacteriaceae on Drigalski medium and *Bacteroides* on Shaedler Neo Vanco medium ([@b18]). Plates were incubated at 37°C under aerobic conditions for 24 h for the counting of Enterobacteriaceae, and under anaerobic conditions during 48 h for *Bifidobacteria*, *Lactobacillus*, *Bacteroides* and *C. perfringens*.

Gas chromatography analysis of cecal contents
---------------------------------------------

Fecal SCFAs in cecum were analyzed using gas chromatography flame-ionization-detection (GC-FID). An aliquot of cecal content was extracted with 4 ml buffer (0.1% (w/v) HgCl~2~ and 1% (v/v) H~3~PO~4~) supplemented with 0.045 mg/ml 2,2-dimethylbutyric acid (as internal standard) per gram fresh weight. The resulting slurry was centrifuged for 30 min at 5000 *g* at 4°C, and the SCFAs in the supernatant collected were analyzed using a GC (HP 6890) equipped with flame ionization detector (FID) and a DB-FFAP column (J&W Scientific, MSP Friedli and Co., Switzerland) of 30 m length, 530 μm diameter and 1 μm film thickness. The system was run with helium gas at an inlet constant pressure of 10 psi at 180°C. Each sample run was preceded with a cleaning injection of 1.2% formic acid. Samples were run at an initial temperature of 80°C for 1.2 min, then at 145°C for 6.5 min, at 200°C for 0.55 min and at 200°C for 0.5 min. SCFAs were identified using external standards consisting of authentic acetate, propionate, iso-butyrate, *n*-butyrate, iso-valerate and *n*-valerate, and the concentration was calculated using internal standard.

^1^H NMR spectroscopic analysis
-------------------------------

Plasma samples were prepared by adding saline solution containing 10% D~2~O (serving as a spectrometer field frequency lock) into 100 μl of blood plasma to a total volume of 550 μl. Urine samples were prepared by mixing 20 μl of samples with 30 μl of a deuterated phosphate buffer solution (90% D~2~O, 10% H~2~O) containing 0.25 mM 3-trimethylsilyl-1-\[2,2,3,3-^2^H~4~\] propionate (TSP) as chemical shift reference (δ 0.0). Ileal flushes were sonicated at ambient temperature (298 K) for 30 min to destroy bacterial cells and then centrifuged at 13 000 r.p.m. for 15 min. Aliquots of 300 μl were mixed with 300 μl of a solution containing 90% D~2~O and 0.25 mM TSP. Intact liver samples were bathed in 0.9% saline D~2~O solution. A portion of the tissue (∼15 mg) was inserted into a zirconium oxide 4 mm outer diameter rotor, using an insert to make a spherical sample volume of 25 μl.

All ^1^H NMR spectra were recorded on a Bruker DRX 600 NMR spectrometer (Rheinstetten, Germany) operating at 600.11 MHz for ^1^H observation. ^1^H NMR spectra of plasma, urine and ileal flushes were acquired with a Bruker 5 mm TXI triple resonance probe at 298 K. ^1^H NMR spectra of intact liver tissues were acquired under magic-angle-spinning conditions at a spin rate of 5000 Hz ([@b65]). Tissue samples were regulated at 283 K using cold N~2~ gas during the acquisition of the spectra to minimize any time-dependent biochemical degradation.

1D ^1^H NMR spectra were obtained from each sample using a standard solvent suppression pulse sequence (RD-90°-*t*~1~-90°-*t*~m~-90°-acquire FID) with *t*~m~ fixed at 100 ms and *t*~1~ at 3 μs ([@b62]). Additional 1D Carr-Purcell-Meiboom-Gill (CPMG) spectra were acquired for plasma and liver samples. CPMG spectra were acquired using the pulse sequence (RD-90°-(*t*-180°-*t*)~*n*~-acquire FID), with a spin--spin relaxation delay, 2*n*τ, of 160 ms for plasma and 200 ms for tissue ([@b55]). The 90° pulse length was 9.0--12 μs. A total of 128 transients were collected into 32 K data points with a pulse recycle delay (RD) of 2 s.

For assignment purposes, 2D COSY ([@b36]) and TOCSY ([@b4]) NMR spectra were acquired on selected samples. Further assignment of the metabolites was also accomplished with the use of STOCSY on 1D spectra ([@b8]).

UPLC--MS materials and methods
------------------------------

The UPLC of ileal flushes was performed on a ACQUITY UPLC™ system (Waters, Milford, MA, USA). Mass Spectrometry was performed on a TOF™ LCT-Premier (Waters MS Technologies, Manchester, UK). Flush samples were first freeze-dried before being diluted to a final concentration of 1 mg/ml with a 1:1 acetonitrile/water solution. Samples were maintained at 4°C, and 10 and 1 μl injections were made into a 10 cm × 2.1 mm ACQUITY™ BEH C18 1.7 μm UPLC column (Waters) maintained in an oven at 40°C. The bile acids eluted under gradient conditions at a flow rate of 500 μl/min from acetonitrile:water=40:60 to 60:40 over 12 min (pH 4).

The Q-TOF mass spectrometer was operated in W-optic path and negative ion mode with a capillary voltage of 2.6 kV, cone voltage of 50 V, nebulizer gas flow of 600 l/h, desolvation temperature of 300°C and a source temperature of 100°C. All analyses were acquired using the lock-spray to ensure mass accuracy and reproducibility, and leucine-enkephalin was used as the lock mass (*m/z* 554.2615) at a concentration of 200 ng/ml and a flow rate of 20 μl/min. Data were collected over 12 min in centroid mode with a lock-spray frequency of 11 s over the mass range *m/z* 50--850 with an acquisition time of 250 ms, an interscan delay of 50 ms and data averaging over 10 scans.

The standards used as bile acid reference materials are listed in [Figure 4](#f4){ref-type="fig"} with the abbreviations, molecular structure, molecular weight and the retention time observed using this UPLC--MS method.

Data preparation
----------------

^1^H NMR spectra were manually phased and baseline-corrected using XwinNMR 3.5 (Bruker Biospin, Rheinstetten, Germany) and referenced to the chemical shift of the CH~3~ resonance of alanine at δ 1.466. The regions containing the water resonance (δ 4.5--5.19), and for urine urea resonance (δ 4.5--6.2), were removed. The spectra were converted into 22 K data points over the range of δ 0.2--10.0 using an in-house-developed MATLAB routine (Dr O Cloarec, personal communication). The spectra were normalized to a constant sum before chemometric analyses.

UPLC--MS data were processed using the Micromass MarkerLynx™ applications manager Version 4.0 (Waters). The peaks of bile acids were identified by comparison to the *m/z* ratio and retention time of a set of standard bile acids ([Figure 4](#f4){ref-type="fig"}). Integration of the UPLC--MS bile acid peaks was performed using ApexTrack2™ peak detection (Waters). Data were noise-reduced in both the UPLC and MS domains using MarkerLynx™. The ion intensities for each bile acid identified were normalized, within each sample, to the sum of the peak intensities in that sample.

Chemometrics: modeling and interpretation
-----------------------------------------

Statistical analysis of the changes in bacterial populations and in the fecal composition in SCFAs obtained by GC-FID was carried out using a two-tailed Mann--Whitney test.

The multivariate pattern recognition techniques used in this study were based on orthogonal projection to latent structure (O-PLS) approach with unit-variance scaling ([@b58]). In O-PLS-DA algorithm, the variation in X (NMR spectra or ion counts) is decomposed into three parts: first, the variation in X (the data matrix) related to Y (the class matrix), and the two last parts contain the specific systemic variation in X and residual, respectively ([@b58]). This leads to a model with a minimal number of predictive components defined by the number of degrees of freedom between group variances. The O-PLS coefficient (covariance) plots are presented using a back-scaling transformation, which preserves the original spectral structure appearance for NMR data ([@b9]). This also allows each data variable to be plotted with a color code, which relates to the significance of class discrimination as calculated from the correlation matrix. The covariance and correlation correspond to the shape and color code respectively. Here, a coefficient of *r*=0.57 was determined according to the test for the significance of the Pearson\'s product-moment correlation coefficient as the cutoff value, which was calculated based on discrimination significance at the level of *P*\<0.05. The standard seven-fold cross-validation method was applied to establish the robustness of the model ([@b21]).

Bipartite graph representation bile acid and fecal flora profiles
-----------------------------------------------------------------

To explore the possible transgenomic interactions between gut microbes and the host\'s metabolism, functional correlation networks were derived from bile acid and fecal flora profiles correlation coefficients using the bipartite graph Rgraphsviz package from R to represent the correlation matrix. Pearson\'s correlation coefficients were computed between bile acid variables and fecal flora variables from the same animals. A cutoff was then applied to the absolute value of the coefficient ∣*r*∣, so that absolute correlations ∣*r*∣\>cutoff were set to 1 and absolute correlations ∣*r*∣\<cutoff were set to 0, thus defining the adjacency matrix for the graph (defining connections between entities). Hence, *G*=(*N*, *E*) specifies a graph *G* with *N* denoting the two node sets (two types of nodes: bile acids and fecal flora) and *E* the edge set (link between nodes, here a correlation between bile acids and fecal flora above the cutoff, i.e. ∣*r*∣\>0.5). The bipartite graph represents only the correlations between the two types of nodes (fecal flora and bile acids). In that context, presence of edges between two specific nodes (one of each type) reveals a functional correlation (above the cutoff) between these two entities. On the graph, the edges were then color-coded to represent the sign of the initial correlation (blue negative, orange positive) and the correlation value was displayed. To assess the pattern of correlations between fecal flora and bile acids, several correlation cutoff values were tested. For each correlation cutoff value, the number of edges connected to each was then computed to assess the degree of the network (number of edges connected to the most connected node).
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![Metabolism and synthesis of the major bile acids in mouse. Key: Color denotes family of bile acids, that is, primary bile acids synthesized in liver in black, secondary bile acids synthesized in liver and processed by microflora in green and tertiary bile acids synthesized in liver, processed by microflora and re-metabolized in liver through enterohepatic recirculation in orange. Conjugation with taurine and glycine is colored in blue and red respectively. Key intermediates in the pathway are colored in gray.](msb4100153-f1){#f1}

![Typical 600 MHz ^1^H NMR spectra. ^1^H CPMG NMR spectra of plasma (**A**) and intact liver tissue (**B**), and ^1^H NMR spectrum of urine (**C**) from an HBF mouse, and ^1^H NMR spectra of ileal flushes from HBF (**D**) and conventional mice (**E**). The spectra of the urine and ileal flushes were magnified 6 and 10 times respectively in the aromatic region (δ 5.2--8.5) compared to the aliphatic region (δ 0.7--4.5). The liver regions δ 5.2--5.4 and 5.4--8.5 were magnified 4 and 8 times respectively. The plasma regions δ 5.2--5.4 and 5.4--8.5 were magnified 4 and 10 times respectively. Keys to the figures are given in [Table III](#t3){ref-type="table"}.](msb4100153-f2){#f2}

![O-PLS-DA coefficient plots derived from ^1^H NMR spectra. O-PLS-DA coefficient plots derived from ^1^H NMR CPMG spectra of plasma (**A**), ^1^H MAS NMR CPMG spectra of liver (**B**) and ^1^H NMR spectra of urine (**C**) and ileal flushes (**D**) indicating discrimination between conventional (negative) and HBF-colonized mice (positive). The O-PLS-DA coefficient plots are presented using a back-scaling transformation, as described previously ([@b9]), which allows each variable to be plotted with a color code that relates to the significance of class discrimination as calculated from the correlation matrix. Arg, arginine; Asp, aspartate; Asn, asparagine; CA, cholic acid; Gln, glutamine; Gsh, glutathione; GPC, glycerophosphorylcholine; IAG, indoleacetylglycine; Lys, lysine; Nac, *N*-acetyl-glycoproteins; PAG, phenylacetylglycine; TCA, taurocholic acid; TβMCA, Tauro β muricholic acid; TUDCA, tauroursodeoxycholic acid.](msb4100153-f3){#f3}

![Structural and functional study of bile acids. Structures of bile acids and cholesterol (**A**), as characterized in this study. Color denotes family of bile acids, that is, primary (black), secondary (green) and tertiary (orange). Conjugation with taurine and glycine is colored in blue and red respectively. Key intermediates in the pathway are colored in gray. Typical negative ion mass chromatograms from the UPLC--MS analysis (**B**) for the ions detected at the given *m/z* for the ileal flush from a conventional mouse with sample injections of 10 μl (1 μl for *m/z*=514.2). Numbers under the *m/z* ratios are the total ion counts for that chromatogram.](msb4100153-f4){#f4}

![O-PLS-DA coefficient plots derived from the UPLC--MS bile acid composition. O-PLS-DA coefficient plots derived from the bile acid composition obtained by UPLC--MS analysis of ileal flushes, indicating discrimination between conventional (positive) and HBF colonized mice (negative) (**A**), and partial discrimination between conventional (positive) and re-conventionalized mice (negative) (**B**). The color code corresponds to the correlation coefficients of the variables. One predictive and one orthogonal components were calculated, and the respective (*Q*^2^*Y*, *R*^2^*X*) are (89.1%, 80%) and (51.4%, 62%). The O-PLS-DA coefficient plots are presented using a back-scaling transformation, as described previously ([@b9]), which allows each variable to be plotted with a color code that relates to the significance of class discrimination as calculated from the correlation matrix.](msb4100153-f5){#f5}

![Effect of major bile acids on organ-specific metabolic profiles. O-PLS coefficient plots describing correlation between ^1^H NMR spectra of ^1^H MAS NMR CPMG spectra of liver (**A, C**) and ileal flushes (**B, D**) and ileal concentrations of cholic acid (A, B) and taurocholic acid (C, D), as measured using UPLC--MS. The O-PLS coefficients plots are presented using a back-scaling transformation, as described previously ([@b9]), which allows each variable to be plotted with a color code that relates to the significance of correlation as calculated from the correlation matrix. One predictive and two orthogonal components were calculated; the respective (*Q*^2^*Y*, *R*^2^*X*) are (55%, 39%), (47%, 37%), (36%, 44%) and (21%, 41%). CA, cholic acid; TCA, taurocholic acid.](msb4100153-f6){#f6}

![Integration of bile acid and fecal flora correlations. The bipartite graphs were derived from correlations between fecal flora and bile acids in each group: conventional (**A**) or HBF (**B**). *G*=(*N*,*E*) specifies a graph *G* with *N* denoting the node set (bile acids) and *E* the edge set (correlation between bile acids, above a defined cutoff, that is, ∣*r*∣\>0.5), which was defined using network degree statistics (**C**). Bile acids and fecal bacteria correspond to blue ellipse nodes and green rectangle nodes respectively. Edges are coded according to correlation value: positive and negative correlations are respectively displayed in blue and orange. aMA, α-muricholic acid; Ba, *Bacteroides*; Bf, *Bifidobacteria*; bMA, β-muricholic acid; CA, cholic acid; CDCA, chenodeoxycholic acid; Cp, *Clostridium perfringens*; DCA, deoxycholic acid; Eb, *Enterobacteria*; GCA, glycocholic acid; HCA, hyocholic acid; Lb, *Lactobacillus*; OMA, ω-muricholic acid; Sc, *Staphylococcus*; TCA, taurocholic acid; TCDCA, taurochenodeoxycholic acid; TDCA, taurodeoxycholic acid; TMCA, tauro-β-muricholic acid; TUDCA, tauroursocholic acid; UDCA, ursocholic acid.](msb4100153-f7){#f7}

![Microbe--mammalian metabolic interactions related to bile acid and lipid metabolism. The bacterial reprocessing of the bile acid pool and regulation of bile acid metabolism by bacterial SCFAs affect significantly the enterohepatic recirculation and the systemic lipid metabolism, that is, emulsification, absorption, transport of dietary fats. The gut bacterial-induced regulation of enterohepatic recirculation also led to a physiological regulation of oxidative stress (glutathione), reprocessing of fatty acids (deposition, apoprotein and VLDL synthesis) and VLDL secretion from the liver, which result in controlling the influx and efflux of fatty acids in the liver. BA, bile acids; CA, cholic acid; GPC, glycerophosphorylcholine; GSH, glutathione; HBF, human baby flora; LDL, low-density Lipoproteins; βMCA, β-muricholic acid; SCFAs, short-chain fatty acids; TβMCA, tauro-β-muricholic acid; TCA, taurocholic acid; VLDL, very low-density lipoproteins.](msb4100153-f8){#f8}

###### 

Microbial species counts in mouse feces at the end of the experiment

  Groups/log~10~ CFU    Conventional (*N*=10)   Re-conventional (*N*=10)            HBF-*L. paracasei* (*N*=7)
  -------------------- ----------------------- -------------------------- ----------------------------------------------
  *Lactobacilli*               6.4±1.5                  5.9±2.5                              7.1±0.4
  *Enterobacteria*             6.5±1.0               7.8±0.7^\*\*^         9.1±0.4^\*\*\*^[^a^](#t1-fn2){ref-type="fn"}
  *Bifidobacteria*             7.0±1.2                  7.8±1.4                              7.5±0.7
  *Staphylococcus*             4.8±0.7                  4.7±1.0                              5.8±0.4
  *C. perfringens*               \<2                      \<2              7.0±0.9^\*\*\*^[^a^](#t1-fn2){ref-type="fn"}
  *Bacteroides*                8.3±0.4               9.1±0.6^\*\*^                       9.5±0.9^\*\*\*^

![](msb4100153-t1)

Log~10~ of CFU (colony-forming unit) given per gram of wet weight of feces. Data are presented as mean±s.d. The average values for the re-colonized group were compared to the conventional animals: ^\*^significant difference at 95% confidence level, ^\*\*^significant difference at 99% confidence level, ^\*\*\*^significant difference at 99.9% confidence level.

Significant difference at 99.9% confidence level was observed when compared to the re-conventionalized animals.

###### 

Short-chain fatty acid content in the cecum from the different groups

  SCFAs\\microbiota                   Acetate                           Propionate                        Isobutyrate                         Butyrate                           Isovalerate                         Valerate
  -------------------- ------------------------------------- --------------------------------- --------------------------------- ----------------------------------- ----------------------------------- ---------------------------------
  Conventional                 179.1±43.5 (73.7±3.5)                24.4±5.3 (10.2±1.2)                3.1±0.5 (1.3±0.2)                27.1±11.7 (11.1±4.3)                   4.7±1.3 (2±0.4)                    4.2±1 (1.7±0.4)
  Re-conventional          136.6±51.4^\*^ (67±4.2^\*\*^)        26.5±6.4 (14.5±3.7^\*\*\*^)         3.3±0.8 (1.7±0.4^\*\*^)              27.5±13 (12.1±4.3)                   4.6±1.2 (2.5±0.8)                4.5±1.2 (2.2±0.5^\*^)
  HBF-*L. paracasei*    34.4±9.9^\*\*\*^ (65.9±3.1^\*\*\*^)   12.8±4^\*\*\*^ (24.5±4^\*\*\*^)   0.6±0.1^\*\*\*^ (1.2±0.3^\*\*^)   1.9±0.9^\*\*\*^ (4.2±3.4^\*\*\*^)   1.7±0.9^\*\*\*^ (3.3±1.4^\*\*\*^)   0.4±0.1^\*\*\*^ (0.9±0.5^\*\*^)
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Data are presented in μmol/g of dry feces and are presented as means±s.d. The relative composition in short-chain fatty acids in percentage of total content. The average values for the re-colonized group were compared to the conventional animals: ^\*^significant difference at 95% confidence level, ^\*\*^significant difference at 99% confidence level, ^\*\*\*^significant difference at 99.9% confidence level.

###### 

Table of assignment of the metabolites in plasma, liver, urine and ileal flushes

  Key   Metabolites                         Moieties                                                      δ ^1^H (p.p.m.) and multiplicity
  ----- ----------------------------------- ------------------------------------------------------------- ---------------------------------------------------------------------------------
  1     Isoleucine                          αCH, βCH, γCH~3~, δCH~3~                                      3.65(d), 1.95(m), 0.99(t), 1.02(d)
  2     Leucine                             αCH, βCH~2~, δCH~3~, δCH~3~                                   3.72(t), 1.96(m), 0.91(d), 0.94(d)
  3     Valine                              αCH, βCH, γCH~3~                                              3.6(d), 2.26(m), 0.98(d), 1.04(d)
  4     Ethanol                             CH~2~, βCH~3~                                                 3.65(q), 1.18(t)
  5     3-[D]{.smallcaps}-hydroxybutyrate   CH, CH~2~, γCH~3~, CH~2~                                      4.16(dt), 2.41(dd), 1.20(d), 2.31(dd)
  6     Lactate                             αCH, βCH~3~                                                   4.11(q), 1.32(d)
  7     Alanine                             αCH, βCH~3~                                                   3.77(q), 1.47(d)
  8     Arginine                            αCH, βCH~2~, γCH~2~, δCH~2~                                   3.76(t), 1.89(m), 1.63(m), 3.23(t)
  9     Lysine                              αCH, βCH~2~, γCH~2~, δCH~2~, ɛCH~2~                           3.77(t), 1.89(m), 1.72(m), 1.47(m), 3.01(t)
  10    Acetate                             CH~3~                                                         1.91(s)
  11    Threonine                           αCH, βCH~2~, γCH~3~                                           3.59(d), 4.25(m), 1.32(d)
  12    Proline                             αCH, βCH~2~, γCH~2~, δCH~2~                                   4.11(t), 2.02(m)--2.33(m), 2.00(m), 3.34(t)
  13    Glutamate                           αCH, βCH~2~, γCH~2~                                           3.75(m), 2.08(m), 2.34(m)
  14    Methionine                          αCH, βCH~2~, γCH~2~, δCH~3~                                   3.78(m), 2.14(m), 2.6(dd), 2.13(s)
  15    Lipids                              CH~3~, (CH~2~)n, CH~2~-C=C, CH~2~-C=O, =C-CH~2~-C=, -CH=CH-   0.89(m), 1.27(m), 2.0 (m), 2.3(m), 2.78(m), 5.3(m)
  16    Glutamine                           αCH, βCH~2~, γCH~2~                                           3.77(m), 2.15(m), 2.44(m)
  17    Citrate                             CH~2~(2), CH~2~(1)                                            2.55(d), 2.65(d)
  18    Pyruvate                            CH~3~                                                         2.41(s)
  19    Aspartic acid                       αCH, βCH~2~                                                   3.89(m), 2.68(m), 2.82(m)
  20    Asparagine                          αCH, βCH~2~                                                   3.90(m), 2.86(m) 2.94(m)
  21    Creatine                            N-CH~3~, CH~2~                                                3.03(s), 3.92(s)
  22    Glutathione                         CH~2~, CH~2~, S-CH~2~, N-CH, CH                               2.17(m), 2.55(m), 2.95(m), 3.83(m), 4.56(m),
  23    Choline                             N-(CH~3~)3, OCH~2~, NCH~2~                                    3.2(s), 4.05(t), 3.51(t)
  24    Phosphorylcholine                   N(CH~3~)3, OCH~2~, NCH~2~                                     3.22(s), 4.21(t), 3.61(t)
  25    GPC                                 N-(CH~3~)3, OCH~2~, NCH~2~                                    3.22(s), 4.32(t), 3.68(t)
  26    Taurine                             N-CH~2~, S-CH~2~                                              3.26(t), 3.40(t)
  27    Glycine                             CH~2~                                                         3.55(s)
  28    *N*-acetyl-glycoproteins (Nac)      CH~3~                                                         2.04(s)
  29    *O*-acetyl-glycoproteins            CH~3~                                                         2.08(s)
  30    Trimethylamine-*N*-oxide (TMAO)     CH~3~                                                         3.26(s)
  31    Tyrosine                            CH, CH                                                        7.16(dd), 6.87(dd)
  32    Phenylalanine                       2,6-CH, 3,5-CH, 4-CH                                          7.40(m), 7.33(m), 7.35(m)
  33    Tryptamine                          4-CH, 7-CH, 2-CH, 6-CH, 5-CH, CH~2~, CH~2~                    7.70(d), 7.52(d), 7.34(s) 7.29(t), 7.21(t), 3.35(t), 3.18(t)
  34    Glycogen                            Ring protons, CH                                              3.35--4.0(m), 5.38--5.45(m)
  35    α-Glucose                           1-CH                                                          5.24(d)
  36    Scyllo-inositol                     OH                                                            3.34(s)
  37    Indoleacetyl-glycine (IAG)          4-CH, 7-CH, 2-CH, 5-CH, 6-CH, CH~2~, CH~2~                    7.64(d), 7.55(d), 7.35(s) 7.28(t), 7.19(t), 3.82(s), 3.73(s)
  38    Phenylacetyl-glycine (PAG)          2,6-CH, 3,5-CH, 7-CH, 10-CH                                   7.43(m), 7.37(m), 3.75(d), 3.68(s)
  39    3-Hydroxy-isovalerate               CH~3~                                                         1.21(s)
  40    Creatinine                          CH~3~, CH~2~                                                  3.06(s), 4.06(s)
  41    Phosphocreatine                     CH~3~, CH~2~                                                  3.05(s), 3.95(s)
  42    Isobutyrate                         CH~3~, CH                                                     1.11(d), 3.02(m)
  43    α-Ketoisovalerate                   CH~3~, CH                                                     1.13(d), 3.02(m)
  44    Butyrate                            CH~3~, CH~2~, CH~2~                                           0.90(t), 2.16(t), 1.56(m)
  45    α-Keto-isocaproate                  CH~3~, CH, CH~2~                                              0.94(d), 2.10(m), 2.61(d)
  46    Kynurenine                          CH, CH, CH, CH, CH, CH                                        4.16(t), 3.72(d), 7,89(d), 6.82(t), 7.43(t), 6.89(d)
  47    Uridine                             CH, CH, CH, CH, CH, CH, CH~2~, CH~2~                          7.87(d), 5.92(d), 5.9(s), 4.36(t), 4.24(t), 4.14(q), 3.92(dd), 3.81(dd)
  48    Formate                             CH                                                            8.45(s)
  49    Fumarate                            CH                                                            6.53(s)
  50    Citrulline                          CH, CH~2~, CH~2~, CH~2~                                       3.76(t), 3.15(q), 1.88(m), 1.52(m)
  51    2-Oxoglutarate                      CH~2~, CH~2~                                                  3.01(t), 2.45(t)
  52    β-Alanine                           CH~2~, CH~2~                                                  3.19(t), 2.56(t)
  53    Dimethylglycine (DMG)               CH~2~                                                         2.93(s)
  54    Trimethylamine (TMA)                CH~3~                                                         2.91(s)
  55    Inosine                             2-CH, 8-CH, 2′-CH, 4′-CH, 5′-CH, CH~2~, CH~2~                 8.34(s), 8.24(s), 6.1(d), 4.44(t), 4.28(q), 3.92(dd), 3.85(dd)
  56    Putative glycolipid (U1)            CH~3~, CH~2~, ---                                             0.89(m), 1.27(m), 1.56(m), 1.68(m), 2.15(m), 2.25(m), 3.10(m), 3.55(m), 3.60(m)
  57    *p*-Toluyl derivative (U2)          CH~3~, CH~2~, CH~2~, CH~2~                                    2.38(s), 7.31(d), 7.26(d), 5.42(m)
  58    Unknown (U3)                        ---                                                           0.37(t), 0.66(m), 0.74(m), 0.90(m), 1.15(m), 1.35(m), 2.24(m)
  59    Unknown (U4)                        ---                                                           3.49(s), 1.14(d)
  60    Glycerol                            C2-H, CH~2~, CH~2~                                            3.91(m), 3.64(m), 3.56(m)
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s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; dd, doublet of doublet; dt, doublet of triplet.

###### 

O-PLS-DA model summary for discriminating NMR spectra of plasma, urine, liver and ileal flushes

  Discrimination analyzed/sample   Conventional versus re-conventionalized   Conventional versus HBF
  -------------------------------- ----------------------------------------- ------------------------------
  Plasma                           *Q*^2^*Y*=29%, *R*^2^*X*=23%              *Q*^2^*Y*=70%, *R*^2^*X*=28%
  Urine                            *Q*^2^*Y*=40%, *R*^2^*X*=37%              *Q*^2^*Y*=75%, *R*^2^*X*=44%
  Liver                            *Q*^2^*Y*=42%, *R*^2^*X*=54%              *Q*^2^*Y*=46%, *R*^2^*X*=54%
  Ileal flushes                    *Q*^2^*Y* \<0                             *Q*^2^*Y*=35%, *R*^2^*X*=84%

![](msb4100153-t4)

O-PLS models were generated with (1) predictive component and (2) orthogonal components to discriminate between two groups of mice. The *R*^2^*X* value shows how much of the variation in the data set *X* is explained by the model. The *Q*^2^*Y* value represents the predictability of the models and relates to its statistical validity. A negative value indicates that differences between groups are statistically nonsignificant.

###### 

Bile acids composition in gut flushes for the different microbiota

  Microbiota/bile acids    Conventional   Re-conventional     HBF
  ----------------------- -------------- ----------------- ----------
  DCA                        0.7±0.5            1±1            ND
  CDCA                       0.5±0.1          0.2±0.1          ND
  UDCA                       0.5±0.2          0.7±0.6          ND
  CA                         17.7±6.7        12.7±9.1       0.4±0.5
  ωMCA                        0.8±1           0.7±0.5          ND
  αMCA                       0.9±0.7          0.6±0.5       0.3±0.2
  βMCA                        1.6±1           1.9±1.4       0.9±0.7
  HCA                        0.1±0.1          0.1±0.1          ND
  GCA                        0.3±0.1          0.1±0.1          ND
  TDCA                       0.7±0.4          0.6±0.6          ND
  TCDCA                      1.9±1.3          1.1±0.6        3.3±1
  TUDCA                      5.5±2.3          4.7±0.8       6.6±1.4
  TβMCA                      42.6±4.2        52.4±7.6       49.6±4.8
  TCA                       23.2±13.3         22±19.4        38±3.4
  Ratio TCA:CA                 1.4              1.7          118.8
  Ratio TβMCA:βMCA             24.0            27.7           52.0
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NB: Relative composition in bile acids given in percentage of total bile acid content. Species not detected with UPLC-MS experiment are shown as ND.
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